These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 15840110

  • 1. Treatment of psoriasis with topical sirolimus: preclinical development and a randomized, double-blind trial.
    Ormerod AD, Shah SA, Copeland P, Omar G, Winfield A.
    Br J Dermatol; 2005 Apr; 152(4):758-64. PubMed ID: 15840110
    [Abstract] [Full Text] [Related]

  • 2. Topical paricalcitol (19-nor-1 alpha,25-dihydroxyvitamin D2) is a novel, safe and effective treatment for plaque psoriasis: a pilot study.
    Durakovic C, Ray S, Holick MF.
    Br J Dermatol; 2004 Jul; 151(1):190-5. PubMed ID: 15270890
    [Abstract] [Full Text] [Related]

  • 3. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial.
    Liao YH, Chiu HC, Tseng YS, Tsai TF.
    Br J Dermatol; 2007 Nov; 157(5):1005-12. PubMed ID: 17935517
    [Abstract] [Full Text] [Related]

  • 4. Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension.
    van de Kerkhof PC, Segaert S, Lahfa M, Luger TA, Karolyi Z, Kaszuba A, Leigheb G, Camacho FM, Forsea D, Zang C, Boussuge MP, Paolozzi L, Wajdula J.
    Br J Dermatol; 2008 Nov; 159(5):1177-85. PubMed ID: 18673365
    [Abstract] [Full Text] [Related]

  • 5. The efficacy and safety of topically applied indigo naturalis ointment in patients with plaque-type psoriasis.
    Lin YK, Wong WR, Chang YC, Chang CJ, Tsay PK, Chang SC, Pang JH.
    Dermatology; 2007 Nov; 214(2):155-61. PubMed ID: 17341866
    [Abstract] [Full Text] [Related]

  • 6. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
    Lebwohl M, Menter A, Weiss J, Clark SD, Flores J, Powers J, Balin AK, Kempers S, Glinert RJ, Fleming T, Liu Y, Graeber M, Pariser DM.
    J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541
    [Abstract] [Full Text] [Related]

  • 7. A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction.
    Papp KA, Tyring S, Lahfa M, Prinz J, Griffiths CE, Nakanishi AM, Zitnik R, van de Kerkhof PC, Melvin L, Etanercept Psoriasis Study Group.
    Br J Dermatol; 2005 Jun; 152(6):1304-12. PubMed ID: 15948997
    [Abstract] [Full Text] [Related]

  • 8. Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis.
    Lin YK, Chang CJ, Chang YC, Wong WR, Chang SC, Pang JH.
    Arch Dermatol; 2008 Nov; 144(11):1457-64. PubMed ID: 19015420
    [Abstract] [Full Text] [Related]

  • 9. An intra-individual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis.
    Beutner K, Chakrabarty A, Lemke S, Yu K.
    J Drugs Dermatol; 2006 Apr; 5(4):357-60. PubMed ID: 16673804
    [Abstract] [Full Text] [Related]

  • 10. Inefficacy of topical thyroid hormone analogue TriAc in plaque psoriasis: results of a double-blind placebo-controlled trial.
    Vahlquist A, Törmä H, Carlsson B.
    Br J Dermatol; 2004 Aug; 151(2):489-91. PubMed ID: 15327560
    [Abstract] [Full Text] [Related]

  • 11. Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment.
    Carroll CL, Clarke J, Camacho F, Balkrishnan R, Feldman SR.
    Arch Dermatol; 2005 Jan; 141(1):43-6. PubMed ID: 15655140
    [Abstract] [Full Text] [Related]

  • 12. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
    Housman TS, Keil KA, Mellen BG, McCarty MA, Fleischer AB, Feldman SR.
    J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of etanercept in an integrated multistudy database of patients with psoriasis.
    Gordon K, Korman N, Frankel E, Wang H, Jahreis A, Zitnik R, Chang T.
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S101-11. PubMed ID: 16488320
    [Abstract] [Full Text] [Related]

  • 14. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents.
    Kimball AB, Gold MH, Zib B, Davis MW, Clobetasol Propionate Emulsion Formulation Foam Phase III Clinical Study Group.
    J Am Acad Dermatol; 2008 Sep; 59(3):448-54, 454.e1. PubMed ID: 18539358
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of pruritus with topically applied opiate receptor antagonist.
    Bigliardi PL, Stammer H, Jost G, Rufli T, Büchner S, Bigliardi-Qi M.
    J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial.
    Reitamo S, Spuls P, Sassolas B, Lahfa M, Claudy A, Griffiths CE, Sirolimus European Psoriasis Study Group.
    Br J Dermatol; 2001 Sep; 145(3):438-45. PubMed ID: 11531834
    [Abstract] [Full Text] [Related]

  • 19. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
    Gisondi P, Del Giglio M, Cotena C, Girolomoni G.
    Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
    [Abstract] [Full Text] [Related]

  • 20. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
    Zhu X, Wang B, Zhao G, Gu J, Chen Z, Briantais P, Andres P.
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.